Kura Oncology Inc. logo

Kura Oncology Inc.

KURA | NASDAQ
Chart Builder DCF Calculator
$11.60
-$0.13 (-1.11%)
At close: Sep 21, 2026, 4:00 PM ET
$11.51
-$0.09 (-0.78%)
Pre-market: Sep 22, 2026, 8:18 AM ET
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Net Income
-278.67M -173.98M -152.63M -135.84M -130.47M -89.63M
Depreciation & Amortization
-7.46M 848K 849K 759K 558K 194K
Stock-Based Compensation
37.11M 33.9M 28.08M 26.32M 23.58M 12.81M
Other Working Capital
187.1M 270.97M -2.51M -2.18M -706K 707K
Other Non-Cash Items
515K -12.62M -8.94M 1.68M 399K 410K
Deferred Income Tax
n/a n/a n/a n/a 4.6M n/a
Change in Working Capital
184.44M 286.17M 7.82M -2.98M -3.22M 6.38M
Operating Cash Flow
-64.06M 134.32M -124.82M -110.06M -104.55M -69.83M
Capital Expenditures
-6.64M -472K -168K -626K -1.15M -2.17M
Cash Acquisitions
n/a n/a n/a -33.25K 125.69K 97.77K
Purchase of Investments
-761.59M -659.05M -409.82M -270.66M -445.66M -320.96M
Sales Maturities Of Investments
755.13M 557.93M 425.55M 303.91M 319.97M 223.2M
Other Investing Acitivies
n/a n/a n/a 33.25K -125.69K -97.77K
Investing Cash Flow
-13.1M -101.59M 15.56M 32.63M -126.84M -99.94M
Debt Repayment
n/a n/a n/a 10M -7.25M -250K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
n/a 8.6M 1.21M 3.84M -611K 10.25M
Financial Cash Flow
1.79M 154.42M 94.78M 38.57M -3.44M 469.33M
Net Cash Flow
-75.36M 187.14M -14.48M -38.87M -234.82M 299.57M
Free Cash Flow
-70.7M 133.85M -124.99M -110.69M -105.7M -72M
Adj. Free Cash Flow
-107.8M 99.95M -153.07M -137.01M -129.28M -84.81M
Maintenance CapEx
-502.68K n/a -168K -626K -558K -194K
Growth CapEx
-6.14M -472K n/a n/a -589K -1.98M
Owner Earnings
-64.56M 134.32M -124.99M -110.69M -105.11M -70.02M

© 2026 bestshares.com. All rights reserved.